Bis (maltolato) oxovanadium (IV)
Bis (maltolato) oxovanadium (IV) (BMOV) is an orally active, competitive pan-protein tyrosine phosphatase (PTP) inhibitor with insulin-mimetic and anti-diabetic properties. It acts as an insulin sensitizer, improving cardiac function in diabetic models, and potently inhibits PTPs such as PTP1B (IC50 109 nM) and SHP2.
Product Specifications
CAS Number
38213-69-3
Product Name Alternative
Diabetes, Bis (maltolato) oxovanadium, Bis (maltolato) oxovanadium (IV), Bis (maltolato) oxovanadium (IV), Bis maltolato oxovanadium, Bis (maltolato) oxovanadium (IV), bis maltolato oxo vanadium, BMOV, metabolic, inhibit, Inhibitor, insulin, HCPTPA, HPTPß, HPTPβ, glucose, PTP1B, PTP, phenotype, SHP-2, SHP-1, SHP2, Phosphatase, uptake, type-2
Field of Research
Metabolism Research
Purity
99.10% (May vary between batches)
Solubility
DMSO:13 mg/mL (40.99 mM)
Smiles
O=[V+2]12 ([O-]C=3C (=O1) C=COC3C) [O-]C=4C (=O2) C=COC4C
Molecular Formula
C12H10O7V
Molecular Weight
317.15
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog